Dr. Reddy's Laboratories Ltd. closed 17.37% short of its 52-week high of 1,420.20 rupees, which the company achieved on ...

Dr. Reddy's Laboratories Ltd. closed 15.40% below its 52-week high of 1,420.20 rupees, which the company reached on August ...

Pharmaceutical layoffs planned? No, says Dr Reddy's Laboratories, as the drugmaker categorically denied media reports that has undertaken workforce reduction to cut costs by around 25 per cent.

Pharma major Dr. Reddy’s Laboratories has said that the Indian Income Tax Department served a show-cause notice on the company on April 4, asking it to explain why its IT returns for the ...

Kyndryl a provider of enterprise technology services, has partnered with Dr Reddy’s Laboratories to transform Dr Reddy’s IT operations across all locations including manufacturing plants ...

Dr. Reddy's Laboratories has refuted media reports alleging a 25% reduction in workforce costs. The Hyderabad-based pharmaceutical giant dismissed claims of layoffs targeting high-earning ...

On the top analysts' 'buy' list are stocks such as Axis Bank, Dr Reddy's Laboratories, Bharat Heavy Electricals Ltd (BHEL), and Indian Railway Catering and Tourism Corporation (IRCTC). Here is the ...

In this article, we will take a look at where Dr. Reddy’s Laboratories Limited (NYSE:RDY) stands against other best Indian stocks. India’s stock market had a rough ride during the second half ...

Dr. Reddy’s (RDY) commented on a news item published in Business Standard on April 13, with the heading “DRL trims workforce costs by 25% amid Revlimid-linked margin strain.” The company ...

Dr. Reddy's Laboratories, operating in the Pharmaceuticals sector and classified as a Largecap on the BSE, currently has its share price at ₹1186.35. The stock has experienced fluctuations today ...

Dr. Reddy's Laboratories (NYSE:RDY) will be laying off 25% of its workforce as the company moves to offset impacts from ...